An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

PAR-22-228 - Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

For technical issues E-mail OER Webmaster

Redirect Notice

PAR-22-228 - Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Stay Connected

Government Sites

Web Policies and Notices

Site Map